novartis

Novartis Enhances Cardiovascular Pipeline with Tourmaline Bio Acquisition and Pacibekitug for Atherosclerotic Cardiovascular Disease (ASCVD)

Novartis Acquires Tourmaline Bio: A Closer Look at Pacibekitug On September 9, 2025, Novartis announced its plan to acquire Tourmaline ... Read more